Electromed Inc. (ELMD) rated Buy with price target $5 by Feltl & Co.
Electromed Inc. (ELMD) rated
Buy with price target $5 by Feltl & Co.
(Electromed) is engaged in the business of providing airway clearance products applying high frequency chest wall oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The Company manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System (SmartVest System) and related products, to patients with compromised pulmonary function. The SmartVest System generates HFCWO, a technique for airway clearance therapy, also known as High Frequency Chest Compression. The SmartVest System has been approved by the United States Food and Drug Administration (FDA) to treat the condition of excess lung secretions. It may be prescribed to patients suffering from cystic fibrosis, chronic obstructive pulmonary disease, muscular dystrophy, post-surgical airway complications and a variety of other diseases and conditions associated with impaired lung and airway capacity.
Feltl and Company's Research Department is focused on micro to small market capitalization companies that are not widely covered by other research firms. Our research universe is focused and organized around the sectors of Technology, HealthCare, and Leisure/Consumer. Feltl and Company holds its research department to very high standards,
and strives to provide value- added investment ideas through sound fundamental analysis.
Feltl and Company's Research Department includes six senior analysts and one associate analyst with many years of investment analysis experience. Although we are focused on, and committed to, companies in the Upper Midwest, our reach extends from coast to coast. About half of the companies we cover are headquartered outside our "backyard."
Our analysts have significant industry experience and strive to know their companies inside and out. Through stringent analysis, they provide value by creating a disciplined application of company valuation, allowing our clients to make sound investment decisions.